Astrazeneca AZN
NYSE AZN
$171.52 -1.05 (-0.61%)
As of: Oct 23, 2026 · 3:59 PM EDT

Astrazeneca (AZN) Accumulated Expenses (2018 - 2021)

Updated

Astrazeneca (AZN) recorded Accumulated Expenses of -$911 million in Q1 2021.

Analysis

Astrazeneca (AZN) Accumulated Expenses (2018 - 2021) Analysis & Trends

At the end of FY2020, Astrazeneca reported Accumulated Expenses of $1.08 billion, up 21.5% from FY2019.

  • Across earlier years, Accumulated Expenses came in at $892.7 million in FY2019 and $7 million in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Vertex Pharmaceuticals 133.09 Bn 105.09 Bn 2.84 Bn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 -911.00 Mn
Dec 31, 2020 1.08 Bn
Dec 31, 2019 89.27 Mn
Dec 31, 2018 7.00 Mn
API Access

Astrazeneca Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=AZN&period=max&api_key=YOUR_API_KEY